TuesdaySep 17, 2019 12:49 pm

ChineseInvestors.com Inc. (CIIX) Announces 175% Sales Increase, Launch of Six New Hemp-Infused Skincare Products

ChineseInvestors.com is a leading financial information website for Chinese-speaking investors The company reported a 175 percent year-over-year increase in revenue for FY2019 CIIX’s CBD Biotech Inc. division recently launched six new skincare products ChineseInvestors.com Inc. (OTCQB: CIIX) is a foremost financial information website for Chinese-speaking investors in the United States and China. In addition, via its CBD division (CBD Biotech Inc.), the company was focusing on cannabidiol (CBD)-based nutrition and health products. However, the company’s current plan is to return focus to its original mission of providing financial information and services to the larger Chinese community in the United States…

Continue Reading

TuesdaySep 17, 2019 11:50 am

SinglePoint Inc. (SING) to Display 100% American Hemp Cigarette, Direct Solar of America Division Announces Hemp Distribution Centers

SinglePoint Inc. is expected to promote 100 percent American hemp cigarettes at the National Association of Convenience Stores Exhibition SING subsidiary Direct Solar of America recently detailed operations relating to a hemp distribution center SING’s CEO forecasts revenues of more than $10 million for its solar division in 2020 SinglePoint Inc. (OTCQB: SING) will be showcasing a 100 percent American-grown hemp cigarette, its latest product by Pure, at booth 5653 of the National Association of Convenience Stores (NACS) Exhibition. Products at this exhibition, which is attended by more than 23,000 participants, gain industry exposure by being displayed to major chain stores.…

Continue Reading

TuesdaySep 17, 2019 11:40 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Adds Daniel J. Shea as Chief Financial Officer at Pivotal Time for Growth

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Daniel J. Shea has joined the company as its senior vice president and chief financial officer effective Friday, September 13, 2019.  In the key leadership position, Shea’s responsibilities will include directing and overseeing all aspects of the company’s finance and administration functions, including financial reporting and analysis; compliance with GAAP and applicable financial and tax reporting laws and rules; forecasting and budgeting; serving as primary liaison with the company’s independent accounting…

Continue Reading

TuesdaySep 17, 2019 11:37 am

QualityStocksNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) Appoints Consumer Products and Healthcare Industry Veteran Peter Vitulli to its Board

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) this morning announced its appointment of Peter Vitulli to its board of directors. According to the update, Vitulli currently serves as an operating advisor at Windrose Health Investors and has extensive experience spanning 35 years in the consumer products and healthcare industries with both large corporations and entrepreneurial start-ups. Earlier in his career, Peter was president and general manager of the $1 billion North American Gatorade business. He most recently served as president and CEO of DNA Diagnostics Center, one of the world's largest providers of private DNA tests. "I have a long-standing…

Continue Reading

TuesdaySep 17, 2019 11:15 am

QualityStocksNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Executives to Speak, Showcase Innate Compounds at Two Upcoming Events

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founder and CEO, and Mark Lowdell, Ph.D., Co-Founder and Chief Scientific Officer, will be presenting at the first ever Targeting Innate Immunity Congress. Dr. Tesi and Dr. Lowdell will also be instructing a course on the role of the tumor microenvironment (“TME”) in immunosuppression at the event, which will take place September 23rd – 25th in Cambridge, Massachusetts. INmune is set to use this opportunity to showcase its two leading innate compounds…

Continue Reading

TuesdaySep 17, 2019 11:14 am

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Completes Strategic Acquisitions, Reports Record Revenues

The company’s second quarter 2019 financial results included a $5.9 million revenue milestone IONIC Brands has tapped into Nevada’s cannabis market with its acquisition of Vegas Valley Growers North, adding production facilities, four state licenses and a popular vape brand to its portfolio Retail consumer appeal is propelling concentrates toward a forecast $8 billion in retail sales by 2022, outpacing growth in traditional flower sales National cannabis holding company IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3), formerly Zara Resources Inc., capped off the first half of 2019 with record financial results, achieving a milestone of $5.9 million in revenue,…

Continue Reading

TuesdaySep 17, 2019 10:57 am

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate at the Eight Capital & Cassels Brock Global Cannabis Conference

Willow Biosciences Inc. (CSE: WLLW) today announced its plans to participate at the Eight Capital & Cassels Brock Global Cannabis Conference slated to be held at the Shangri-La Hotel in Toronto on September 19, 2019. Willow Biosciences will be available for one-on-one meetings during the event. In addition, Willow CEO, President and Director Trevor Peters will present in the panel, “Pushing the Boundaries Through Technology, Innovation & Research,” at 10:30 a.m. Eastern Time in the Queen's Park Ballroom. To view the full press release, visit http://ibn.fm/BdhG5 About Willow Biosciences Inc. Willow is a Canadian biotechnology company based in Calgary, Alberta,…

Continue Reading

TuesdaySep 17, 2019 10:29 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Partners with John Legend and Casper in Nationwide Launch of 100% Hemp CBD Product Line

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in California, this morning announced the nationwide launch of its first-ever 100% hemp CBD product line. According to the update, a newly established brand partnership between PLUS and American superstar and philanthropist John Legend supports the launch, and Legend will advocate on behalf of the company’s new nationwide hemp CBD product offering. “I have been a believer in the benefits of CBD for some time,” stated Legend. “I was drawn to the PLUS team because they're an innovative, family-run company, and they use science to deliver a consistent,…

Continue Reading

TuesdaySep 17, 2019 10:17 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has engaged with Linneo Health S.L., a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. A European leader in the pharmaceutical cannabis industry, Linneo Health recently received its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish regulatory authorities. According to the update, the multi-year agreement includes increasing supply volumes as VIVO expands in the European medical market. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," VIVO CEO Barry Fishman said in the news release. "We are…

Continue Reading

TuesdaySep 17, 2019 10:03 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe's flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered